Colin Hayward

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

High Resolution

Positron Emission Tomography

Renal Cell Carcinoma

Top Venues

Japanese journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Noboru Nakaigawa, Hisashi Hasumi, Daisuke Utsunomiya, Keisuke Yoshida, Yoshinobu Ishiwata, Takashi Oka, Colin Hayward, Kazuhide Makiyama
Evaluation of PET/CT imaging with [89Zr]Zr-DFO-girentuximab: a phase 1 clinical study in Japanese patients with renal cell carcinoma (Zirdac-JP). Japanese journal of clinical oncology 54 (8) (2024)
Noboru Nakaigawa, Hisashi Hasumi, Daisuke Utsunomiya, Keisuke Yoshida, Yoshinobu Ishiwata, Takashi Oka, Colin Hayward, Kazuhide Makiyama
Evaluation of PET/CT imaging with [89Zr]Zr-DFO-girentuximab: a phase 1 clinical study in Japanese patients with renal cell carcinoma (Zirdac-JP). Japanese journal of clinical oncology 54 (8) (2024)
Noboru Nakaigawa, Hisashi Hasumi, Daisuke Utsunomiya, Keisuke Yoshida, Yoshinobu Ishiwata, Takashi Oka, Colin Hayward, Kazuhide Makiyama
Evaluation of PET/CT imaging with [89Zr]Zr-DFO-girentuximab: a phase 1 clinical study in Japanese patients with renal cell carcinoma (Zirdac-JP). Japanese journal of clinical oncology 54 (8) (2024)
Noboru Nakaigawa, Hisashi Hasumi, Daisuke Utsunomiya, Keisuke Yoshida, Yoshinobu Ishiwata, Takashi Oka, Colin Hayward, Kazuhide Makiyama
Evaluation of PET/CT imaging with [89Zr]Zr-DFO-girentuximab: a phase 1 clinical study in Japanese patients with renal cell carcinoma (Zirdac-JP). Japanese journal of clinical oncology 54 (8) (2024)
Noboru Nakaigawa, Hisashi Hasumi, Daisuke Utsunomiya, Keisuke Yoshida, Yoshinobu Ishiwata, Takashi Oka, Colin Hayward, Kazuhide Makiyama
Evaluation of PET/CT imaging with [89Zr]Zr-DFO-girentuximab: a phase 1 clinical study in Japanese patients with renal cell carcinoma (Zirdac-JP). Japanese journal of clinical oncology (2024)